Clinical Trials Directory

Trials / Completed

CompletedNCT06568978

Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema

Evaluation of Disease Severity, Respiratory Muscle Strength, Respiratory Functions, Functionality, and Quality of Life in Patients With Upper Limb Lymphedema

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Istanbul University - Cerrahpasa · Academic / Other
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of our study is to assess disease severity, respiratory muscle strength, respiratory functions, pectoralis minor muscle shortening, functionality, and quality of life (QoL) in patients with upper limb lymphedema (ULL), and to compare these findings with healthy controls.The disease severity was assessed using the Stillwell classification system; respiratory muscle strength was measured through maximum inspiratory and expiratory intraoral pressures (MIP, MEP, respectively); respiratory functions were evaluated with a spirometer; pectoralis minor muscle shortening was measured with a tape measure; functionality was assessed using the Disabilities of the Arm, Shoulder and Hand (DASH); and QoL was evaluated with the Lymphedema Quality of Life Questionnaire - Arm (LYMQOL-Arm).

Detailed description

The study had a cross-sectional observational study design. The participants were divided into two groups, patients with ULL in Group 1; the healthy individuals were included in Group 2. All assessments for both groups were performed by two different physiotherapists.

Conditions

Interventions

TypeNameDescription
OTHERAssessments of respiratory parametersrespiratory muscle strength, respiratory function test

Timeline

Start date
2023-11-20
Primary completion
2024-06-20
Completion
2024-08-20
First posted
2024-08-23
Last updated
2024-08-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06568978. Inclusion in this directory is not an endorsement.